Study to Evaluate the Pharmacokinetics of Mucinex® 1200 mg Extended-Release Tablet
NCT03633487
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
24
Enrollment
INDUSTRY
Sponsor class
Conditions
Healthy Subjects
Interventions
DRUG:
Mucinex®
Sponsor
Reckitt Benckiser LLC